Article Sidebar
Published:
Sep 6, 2024Keywords:
Article Details
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.
Main Article Content
<i>In vivo</i> acute toxicity, analgesic and anti-inflammatory activities of phenolic extract of <i>Matricaria pubescens</i>
Abstract
Purpose: To evaluate the in vivo acute toxicity, analgesic and anti-inflammatory proprieties of the phenolic extract of Matricaria pubescens (Desf.) Schultz (Asteraceae).
Methods: Acute toxicity assessment was carried out on 18 mice that were divided equally into three groups and treated orally with saline, 2500 and 5000 mg/kg of M. pubescens extract, respectively. The evaluation of peripheral analgesic activity was done by applying acetic acid-induced contortion test on 40 mice. The mice were divided into 5 equal groups of 8 mice each. Negative and positive control groups were treated orally with saline (1 %) and acetylsalicylic acid (200 mg/kg), respectively. Other groups were treated with 50, 100 and 200 mg/kg of M. pubescens extract. Study groups were administered saline, diclofenac potassium (10 mg/kg) and M. pubescens extract orally at 50, 100, and 200 mg/kg. Central analgesic activity was carried out using the tail immersion test. The distribution and treatment of the mice was similar to the analgesic model. Anti-inflammatory effect was evaluated by carrageenan-induced mice paw edema.
Results: Acute toxicity results showed that the LD50 of M. pubescens phenolic extract is above 5000 mg/kg, which means that this extract is safe. Peripheral and central analgesic data revealed that different doses of extract significantly inhibited abdominal contractions and reduced pain caused by heat compared to control (p ˂ 0.05). Anti-inflammatory activity data indicate significant inhibition of inflammatory edema at various doses compared to diclofenac potassium (p ˂ 0.05).
Conclusion: The phenolic extract of M. pubescens exerts significant peripheral, central analgesic and anti-inflammatory activities in mice. However, further investigations are required to ascertain the potentials of the extract for its clinical development.
